Related content

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib

By Maiello Monica   D’Alessio Amelia   Luca Antonella   Carotenuto Adele   Rachiglio Anna   Napolitano Maria   Cito Letizia   Guzzo Antonella   Normanno Nicola  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 275-282

Springer Publishing Company

Access to resources Recommend Favorite

Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 526-532

Spandidos Publications

Access to resources Recommend Favorite

Continuous exposure of nonsmall cell lung cancer cells with wildtype EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3

By                  

International Journal of Oncology, Vol. 46, Iss. 5, 2015-01 ,pp. : 2083-2095

Spandidos Publications

Access to resources Recommend Favorite

Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models

By Chen Jianping   Smith Melissa   Kolinsky Kenneth   Adames Violeta   Mehta Nila   Fritzky Luke   Rashed Mohammad   Wheeldon Eric   Linn Michael   Higgins Brian  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 651-659

Springer Publishing Company

Access to resources Recommend Favorite

Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1499-1504

Spandidos Publications

Access to resources Recommend Favorite